This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Mystery Checkpoint Revealed: KIR3DL3 Finally Found a Ligand in HHLA2
Cancer Immunol Res. 2021 Feb;9(2) :128
PMID: 33536266 URL: https://www.ncbi.nlm.nih.gov/pubmed/33536266
AbstractInhibitory killer cell immunoglobulin-like receptors (iKIR) tolerize natural killer cells and some T cells upon detecting classical HLA class I molecules. In this issue, Bhatt and colleagues identify the B7 family member HHLA2 as an unanticipated ligand for a peculiar iKIR family member, KIR3DL3. These data establish a new inhibitory checkpoint pathway that may protect HHLA2(+) tumor cells from immune attack.See article by Bhatt et al., p. 156.
Notes2326-6074 Campbell, Kerry S Journal Article United States Cancer Immunol Res. 2021 Feb;9(2):128. doi: 10.1158/2326-6066.CIR-20-0996.